TextbookSurgerySurgical Site Infection

Surgical Site Infection

SSI is an infection occurring within 30 days of surgery (or 1 year if an implant is placed). It is the most common healthcare-associated infection in surgical patients, affecting 3-5% of operations.

MRCSPLAB 1UKMLA96 questions

Key Facts

Most common healthcare-associated infection in surgical patients; affects ~3-5% of all surgical procedures Classification: Superficial incisional (skin/subcutaneous), deep incisional (fascia/muscle), organ/space (e.g., intra-abdominal abscess) Most common organisms: Staphylococcus aureus (most common overall), coagulase-negative staphylococci (implants), E. coli (abdominal surgery) Risk factors: Contaminated/dirty surgery, obesity, diabetes, smoking, immunosuppression, ASA grade ≥3, prolonged surgery, emergency surgery Wound classification: Clean (1-2% SSI), clean-contaminated (3-5%), contaminated (5-10%), dirty (10-40%) Prophylactic antibiotics: Single dose at induction for clean-contaminated and contaminated surgery; not routinely for clean surgery unless implant NICE NG125: SSI prevention and treatment guidelines MRSA screening: Pre-operative screening and decolonisation (mupirocin nasal ointment + chlorhexidine body wash) reduces SSI

Overview

Key Facts

SSI is a significant cause of post-operative morbidity, prolonged hospital stay, increased cost, and mortality. Prevention through best practice ('care bundles') is more effective than treatment.

Epidemiology

~3-5% of all surgical procedures; higher in emergency surgery (~10%). Accounts for ~16% of all healthcare-associated infections in UK. Increases hospital stay by ~7-10 days. Estimated cost: ~£10,000 per SSI episode.

Aetiology

Patient factors: Obesity, diabetes, smoking, malnutrition, immunosuppression, extremes of age, chronic disease Surgical factors: Wound classification, surgical duration, technique, emergency surgery, foreign body/implant, drains, hypothermia, hyperglycaemia Microbial factors: MRSA carriage, pre-existing infection, wound contamination

Pathophysiology

  • Bacterial contamination of surgical wound → exceeds host defence capacity → infection
  • 10⁵ organisms per gram of tissue generally required for infection (lower threshold with foreign body/implant)

  • Biofilm formation on implants → chronic infection resistant to antibiotics

Clinical Presentation

Superficial SSI (Most Common)

  • Within 30 days of surgery
  • Involves skin and subcutaneous tissue only
  • Erythema, warmth, swelling, tenderness around wound
  • Purulent discharge
  • Wound dehiscence may occur

Deep SSI

  • Involves fascia and/or muscle layers
  • May present with deep wound abscess
  • Fever, pain, systemic sepsis possible

Organ/Space SSI

  • Infection in any part of the body opened/manipulated during surgery (excluding the incision)
  • e.g., Intra-abdominal abscess after laparotomy, empyema after thoracotomy
  • May present days-weeks post-operatively with fever, pain, or sepsis

Red Flags

  • Systemic sepsis (fever, tachycardia, hypotension) with wound signs
  • Rapidly spreading wound infection — consider necrotising fasciitis
  • Prosthetic joint infection — orthopaedic emergency
  • Sternal wound infection post-cardiac surgery — high mortality

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
Normal post-operative inflammationMild warmth/redness in first 48-72 hours, improvingClinical
Wound haematomaSwelling, bruising, no pus or feverUS
SeromaFluctuant collection, clear fluid, no infection signsUS, aspiration
Allergic reaction to dressingErythema matching dressing pattern, itchingClinical
Necrotising fasciitisRapidly spreading, severe pain, systemic toxicityClinical — emergency surgery

Diagnosis / Investigation

Bedside

  • Wound assessment: Signs of infection (rubor, calor, tumor, dolor, pus)
  • Wound swab: If purulent discharge — send for MC&S (not routine for surveillance)
  • Observations: NEWS2

Bloods

  • FBC, CRP: Raised WCC and CRP
  • Blood cultures: If systemic sepsis
  • Procalcitonin: May help guide antibiotic duration

Imaging

  • USS: Wound collection/abscess
  • CT: Deep/organ-space SSI (e.g., intra-abdominal abscess)
  • MRI: Prosthetic joint infection, osteomyelitis

Management

Prevention (NICE NG125 — SSI Care Bundle)

  • Pre-operative: MRSA screening and decolonisation, smoking cessation, glucose optimisation, nutritional optimisation, hair removal with clippers (not razor), skin preparation (2% chlorhexidine in 70% isopropyl alcohol)
  • Intraoperative: Prophylactic antibiotics at induction (within 60 minutes before incision), maintain normothermia (>36°C), meticulous surgical technique, minimise tissue handling
  • Post-operative: Sterile dressing for 48 hours, hand hygiene, appropriate wound care

Prophylactic Antibiotics

  • Clean surgery without implant: Not routinely indicated
  • Clean with implant: Single dose at induction (e.g., cefazolin 2g IV)
  • Clean-contaminated: Single dose at induction (e.g., co-amoxiclav 1.2g IV)
  • Contaminated/dirty: Therapeutic course of antibiotics (not just prophylaxis)

Treatment of Established SSI

  • Superficial: Open wound, drain pus, irrigate; may not need systemic antibiotics if localised
  • Deep/organ-space: IV antibiotics (guided by cultures); drainage of collections (percutaneous or surgical)
  • Implant-related infection: Often requires implant removal, debridement, prolonged antibiotics
  • MRSA SSI: Vancomycin 15-20mg/kg IV BD or linezolid 600mg IV/PO BD

Referral Criteria

  • Deep/organ-space SSI — surgical team
  • Prosthetic joint infection — orthopaedic specialist
  • MRSA infection — microbiology advice

Prognosis

  • Superficial SSI: Usually resolves with local wound care; minimal morbidity
  • Deep/organ-space SSI: Significant morbidity; may require reoperation; mortality ~5-10% in severe cases
  • Prosthetic joint infection: Complex; may require implant removal; long-term functional impact
  • Increased hospital stay: ~7-10 days per SSI episode
  • Financial cost: ~£10,000 per SSI episode
  • Prevention: Care bundles reduce SSI rates by 30-50%

Other Relevant Information

Wound Classification (CDC)

ClassDefinitionSSI RateExample
CleanNo entry to hollow viscus, no inflammation1-2%Hernia repair, thyroidectomy
Clean-contaminatedControlled entry to hollow viscus3-5%Cholecystectomy, appendicectomy
ContaminatedSpillage from viscus, fresh traumatic wound5-10%Penetrating trauma, gross spillage
DirtyEstablished infection, perforated viscus10-40%Perforated appendicitis, abscess drainage